-+ 0.00%
-+ 0.00%
-+ 0.00%

*XTL Biopharmaceuticals Will Acquire 85% of NeuroNOS for Consideration Including 19.9% of XTL's Issued Shr Cap, $1M in Cash, and Milestone-Based Contingent Payments Totaling Up to $32.5M >XTLB

Dow Jones·01/13/2026 14:29:00

Please log in to view news